Compare Invesco Ltd. (IVZ) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco Ltd. vs Procter & Gamble Co — how do they compare? Invesco Ltd. trades at $30.09 (market cap $13.47B), while Procter & Gamble Co trades at $150.55 (market cap $343.34B). The key difference: Procter & Gamble Co is far larger — about 25.5× Invesco Ltd.'s market cap, and Procter & Gamble Co pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold Invesco Ltd. for 77 Days and Procter & Gamble Co for 131 Days on average.
| IVZ | PG | |
|---|---|---|
Market Cap | $13.47B | $343.34B |
Volume | 4,447,526 | 8,662,344 |
Sector | Financials | Consumer Staples |
52-Week High | $33.31 | $167.18 |
52-Week Low | $22.44 | $138.10 |
Typical Hold Time | 77 Days | 131 Days |
Enterprise Value | $23.63B | $369.18B |
Dividend Yield | 2.82% | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Invesco (IVZ) trades at $30.09, down 0.95% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $281.70 million for 2025 despite revenue growth to $6.38 billion, with a negative net margin of -0.93%. Recent earnings have been mixed, beating in Q4 2025 and Q2 2026 but missing in Q1 2026, while Q3 2026 results are pending. Positive developments include strong operating cash flow of $1.53 billion in 2025 and the expansion of its QQQ ETF suite.
The outlook is cautiously optimistic, supported by a consensus price target of $33.71 and no sell ratings among analysts. Key opportunities lie in continued AUM growth and ETF innovation, but risks include profitability challenges and market volatility. The stock's current price near support at $30.00 suggests limited downside if fundamentals improve with upcoming earnings.
Procter & Gamble (PG) trades at $150.59, up 1.47% today, with a bullish technical signal from moving averages and a consensus analyst price target of $160.13. The company reported revenue of $84.28 billion in 2025, with net income of $15.97 billion and strong profitability margins. Recent earnings have consistently beaten expectations, and the stock offers a dividend yield with a history of increases.
PG presents a stable investment with consistent earnings and dividend growth, supported by a robust balance sheet. Risks include premium valuation multiples and modest revenue growth outlook. Analyst sentiment is predominantly positive, with 53% buy ratings, but investors should monitor competitive pressures and economic sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
